Mitigation of Adverse Clinical Events of a Narrow Target Therapeutic Index Compound through Modified Release Formulation Design: An in Vitro, in Vivo, in Silico, and Clinical Pharmacokinetic Analysis (Q40356604)
Jump to navigation
Jump to search
scientific article published on 4 November 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mitigation of Adverse Clinical Events of a Narrow Target Therapeutic Index Compound through Modified Release Formulation Design: An in Vitro, in Vivo, in Silico, and Clinical Pharmacokinetic Analysis |
scientific article published on 4 November 2015 |
Statements
1 reference
Mitigation of Adverse Clinical Events of a Narrow Target Therapeutic Index Compound through Modified Release Formulation Design: An in Vitro, in Vivo, in Silico, and Clinical Pharmacokinetic Analysis (English)
1 reference
David J Good
1 reference
Ruiling Hartley
1 reference
Neil Mathias
1 reference
John Crison
1 reference
Giridhar Tirucherai
1 reference
Peter Timmins
1 reference
Munir Hussain
1 reference
Raja Haddadin
1 reference
Otilia Koo
1 reference
Faranak Nikfar
1 reference
Nga Kit Eliza Fung
1 reference
4 November 2015
1 reference
1 reference
12
1 reference
12
1 reference
4434-4444
1 reference
Identifiers
1 reference
1 reference